Evolus (EOLS)
(Delayed Data from NSDQ)
$6.29 USD
-0.13 (-2.02%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $6.41 +0.12 (1.91%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Evolus, Inc. has a market cap of $415.28M, which represents its share price of $6.42 multiplied by its outstanding shares number of 64.68M. As a small-cap company, EOLS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
EOLS 6.29 -0.13(-2.02%)
Will EOLS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EOLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EOLS
Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates
Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
EOLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline
Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates
SNDL Inc. (SNDL) Reports Q1 Loss, Misses Revenue Estimates
Other News for EOLS
Is EOLS showing upside potential? Stochastic Buy Signal shows up after sinking 1.53%
EOLS forms Lower Bollinger Band Walk on September 18
EOLS falls 1.66% on September 16, leaving the technical picture intact
MACD Bearish Signal Line Cross appears for EOLS after 7.79% move
Is EOLS signaling selling opportunity? Fell Below 20 Day Moving Average shows up after sliding 4.26%